Cargando…
Treatment of intraoperative hypotension with cafedrine/theodrenaline versus ephedrine: A prospective, national, multicenter, non-interventional study—the HYPOTENS trial
BACKGROUND: Sympathomimetic drugs are a therapeutic cornerstone for the management of hypotensive states like intraoperative hypotension (IOH). While cafedrine/theodrenaline (C/T) is widely used in Germany to restore blood pressure in patients with IOH, more research is required to compare its effec...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Medizin
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026467/ https://www.ncbi.nlm.nih.gov/pubmed/33170310 http://dx.doi.org/10.1007/s00101-020-00877-5 |
_version_ | 1783675680351846400 |
---|---|
author | Eberhart, L. Geldner, G. Kowark, A. Zucker, T.-P. Kreuer, S. Przemeck, M. Huljic, S. Koch, T. Keller, T. Weber, S. Kranke, P. |
author_facet | Eberhart, L. Geldner, G. Kowark, A. Zucker, T.-P. Kreuer, S. Przemeck, M. Huljic, S. Koch, T. Keller, T. Weber, S. Kranke, P. |
author_sort | Eberhart, L. |
collection | PubMed |
description | BACKGROUND: Sympathomimetic drugs are a therapeutic cornerstone for the management of hypotensive states like intraoperative hypotension (IOH). While cafedrine/theodrenaline (C/T) is widely used in Germany to restore blood pressure in patients with IOH, more research is required to compare its effectiveness with alternatives such as ephedrine (E) that are more commonly available internationally. METHODS: HYPOTENS (NCT02893241, DRKS00010740) was a prospective, national, multicenter, open-label, two-armed, non-interventional study that compared C/T with E for treatment of IOH. We describe a prospectively defined cohort of patients ≥50 years old with comorbidities undergoing general anesthesia induced with propofol and fentanyl. Primary objectives were to examine treatment precision, rapidity of onset and the ability to restore blood pressure without relevant increases in heart rate. Secondary endpoints were treatment satisfaction and the number of required additional boluses or other accompanying measures. RESULTS: A total of 1496 patients were included in the per protocol analysis. Overall, effective stabilization of blood pressure was achieved with both C/T and E. Post-hoc analysis showed that blood pressure increase from baseline was more pronounced with C/T. Fewer additional boluses or other accompanying measures were required in the C/T arm. The incidence of tachycardia was comparable between groups. Post-hoc analysis showed that E produced dose-dependent elevated heart rate values. By contrast, heart rate remained stable in patients treated with C/T. Physicians reported a higher level of treatment satisfaction with C/T, with a higher proportion of anesthetists rating treatment precision and rapidity of onset as good or very good when compared with E. CONCLUSION: Neither drug was superior in restoring blood pressure levels; however, post-hoc analyses suggested that treatment is more goal-orientated and easier to control with C/T. Heart rate was shown to be more stable with C/T and fewer additional interventions were required to restore blood pressure, which could have contributed to the increased treatment satisfaction reported by anesthetists using C/T. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00101-020-00877-5) contains one further table and two figures. The article and additional material are available at www.springermedizin.de. Please enter the title of the article in the search field. You will find the additional material under “Ergänzende Inhalte” in the article. [Image: see text] |
format | Online Article Text |
id | pubmed-8026467 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Medizin |
record_format | MEDLINE/PubMed |
spelling | pubmed-80264672021-04-26 Treatment of intraoperative hypotension with cafedrine/theodrenaline versus ephedrine: A prospective, national, multicenter, non-interventional study—the HYPOTENS trial Eberhart, L. Geldner, G. Kowark, A. Zucker, T.-P. Kreuer, S. Przemeck, M. Huljic, S. Koch, T. Keller, T. Weber, S. Kranke, P. Anaesthesist Originalien BACKGROUND: Sympathomimetic drugs are a therapeutic cornerstone for the management of hypotensive states like intraoperative hypotension (IOH). While cafedrine/theodrenaline (C/T) is widely used in Germany to restore blood pressure in patients with IOH, more research is required to compare its effectiveness with alternatives such as ephedrine (E) that are more commonly available internationally. METHODS: HYPOTENS (NCT02893241, DRKS00010740) was a prospective, national, multicenter, open-label, two-armed, non-interventional study that compared C/T with E for treatment of IOH. We describe a prospectively defined cohort of patients ≥50 years old with comorbidities undergoing general anesthesia induced with propofol and fentanyl. Primary objectives were to examine treatment precision, rapidity of onset and the ability to restore blood pressure without relevant increases in heart rate. Secondary endpoints were treatment satisfaction and the number of required additional boluses or other accompanying measures. RESULTS: A total of 1496 patients were included in the per protocol analysis. Overall, effective stabilization of blood pressure was achieved with both C/T and E. Post-hoc analysis showed that blood pressure increase from baseline was more pronounced with C/T. Fewer additional boluses or other accompanying measures were required in the C/T arm. The incidence of tachycardia was comparable between groups. Post-hoc analysis showed that E produced dose-dependent elevated heart rate values. By contrast, heart rate remained stable in patients treated with C/T. Physicians reported a higher level of treatment satisfaction with C/T, with a higher proportion of anesthetists rating treatment precision and rapidity of onset as good or very good when compared with E. CONCLUSION: Neither drug was superior in restoring blood pressure levels; however, post-hoc analyses suggested that treatment is more goal-orientated and easier to control with C/T. Heart rate was shown to be more stable with C/T and fewer additional interventions were required to restore blood pressure, which could have contributed to the increased treatment satisfaction reported by anesthetists using C/T. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00101-020-00877-5) contains one further table and two figures. The article and additional material are available at www.springermedizin.de. Please enter the title of the article in the search field. You will find the additional material under “Ergänzende Inhalte” in the article. [Image: see text] Springer Medizin 2020-11-10 2021 /pmc/articles/PMC8026467/ /pubmed/33170310 http://dx.doi.org/10.1007/s00101-020-00877-5 Text en © The Author(s) 2020, korrigierte Publikation 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Originalien Eberhart, L. Geldner, G. Kowark, A. Zucker, T.-P. Kreuer, S. Przemeck, M. Huljic, S. Koch, T. Keller, T. Weber, S. Kranke, P. Treatment of intraoperative hypotension with cafedrine/theodrenaline versus ephedrine: A prospective, national, multicenter, non-interventional study—the HYPOTENS trial |
title | Treatment of intraoperative hypotension with cafedrine/theodrenaline versus ephedrine: A prospective, national, multicenter, non-interventional study—the HYPOTENS trial |
title_full | Treatment of intraoperative hypotension with cafedrine/theodrenaline versus ephedrine: A prospective, national, multicenter, non-interventional study—the HYPOTENS trial |
title_fullStr | Treatment of intraoperative hypotension with cafedrine/theodrenaline versus ephedrine: A prospective, national, multicenter, non-interventional study—the HYPOTENS trial |
title_full_unstemmed | Treatment of intraoperative hypotension with cafedrine/theodrenaline versus ephedrine: A prospective, national, multicenter, non-interventional study—the HYPOTENS trial |
title_short | Treatment of intraoperative hypotension with cafedrine/theodrenaline versus ephedrine: A prospective, national, multicenter, non-interventional study—the HYPOTENS trial |
title_sort | treatment of intraoperative hypotension with cafedrine/theodrenaline versus ephedrine: a prospective, national, multicenter, non-interventional study—the hypotens trial |
topic | Originalien |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026467/ https://www.ncbi.nlm.nih.gov/pubmed/33170310 http://dx.doi.org/10.1007/s00101-020-00877-5 |
work_keys_str_mv | AT eberhartl treatmentofintraoperativehypotensionwithcafedrinetheodrenalineversusephedrineaprospectivenationalmulticenternoninterventionalstudythehypotenstrial AT geldnerg treatmentofintraoperativehypotensionwithcafedrinetheodrenalineversusephedrineaprospectivenationalmulticenternoninterventionalstudythehypotenstrial AT kowarka treatmentofintraoperativehypotensionwithcafedrinetheodrenalineversusephedrineaprospectivenationalmulticenternoninterventionalstudythehypotenstrial AT zuckertp treatmentofintraoperativehypotensionwithcafedrinetheodrenalineversusephedrineaprospectivenationalmulticenternoninterventionalstudythehypotenstrial AT kreuers treatmentofintraoperativehypotensionwithcafedrinetheodrenalineversusephedrineaprospectivenationalmulticenternoninterventionalstudythehypotenstrial AT przemeckm treatmentofintraoperativehypotensionwithcafedrinetheodrenalineversusephedrineaprospectivenationalmulticenternoninterventionalstudythehypotenstrial AT huljics treatmentofintraoperativehypotensionwithcafedrinetheodrenalineversusephedrineaprospectivenationalmulticenternoninterventionalstudythehypotenstrial AT kocht treatmentofintraoperativehypotensionwithcafedrinetheodrenalineversusephedrineaprospectivenationalmulticenternoninterventionalstudythehypotenstrial AT kellert treatmentofintraoperativehypotensionwithcafedrinetheodrenalineversusephedrineaprospectivenationalmulticenternoninterventionalstudythehypotenstrial AT webers treatmentofintraoperativehypotensionwithcafedrinetheodrenalineversusephedrineaprospectivenationalmulticenternoninterventionalstudythehypotenstrial AT krankep treatmentofintraoperativehypotensionwithcafedrinetheodrenalineversusephedrineaprospectivenationalmulticenternoninterventionalstudythehypotenstrial AT treatmentofintraoperativehypotensionwithcafedrinetheodrenalineversusephedrineaprospectivenationalmulticenternoninterventionalstudythehypotenstrial |